Dec 12,2018

Nemaura to Present SugarBEAT® Clinical Performance Poster at ATTD, Berlin

Nemaura Medical Inc., a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes and pre-diabetics, today announced that the Advanced Technologies and Treatments for Diabetes (ATTD) Conference has accepted its sugarBEAT® Clinical Performance Data Abstract for poster presentation at Berlin in February 2019.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Dec 18,2018

Nemaura Medical Announces Pricing of Up to $2.5 Million Public Offering

Nemaura Medical Inc., a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes and pre-diabetics, today announced the pricing of a “best efforts” public offering of Company’s shares of common stock and warrants with expected total gross proceeds of up to $2.5 million.

View Analyst & Ambassador Comments
Go to original news
Dec 18,2018

Nemaura Publishes Positive Data from SugarBEAT® FDA Clinical Trial

Nemaura Medical Inc., a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes and pre-diabetics, today published clinical data from its recently completed study intended to support a De Novo submission to the U.S Food & Drug Administration (“FDA”) for approval of its sugarBEAT® product.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 18,2018

Insulet to Present at the 37th Annual J.P. Morgan Healthcare Conference

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 8, 2019, at 11:30 a.m. (Pacific Time). The presentation will be followed by a Q&A session at noon (Pacific Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Dec 19,2018

Nemaura to Host Investor Webinar on December 21 to Provide Update on Recent Developments

Nemaura Medical Inc., a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes and pre-diabetics, will host an investor webinar and live Q&A session on Friday, December 21, at 10:00 a.m. EST.

View Analyst & Ambassador Comments
Go to original news
Dec 19,2018

John Hancock and One Drop Partner to Empower People Living with Diabetes to Improve Their Health and Financial Wellness

Today, John Hancock announced a partnership with One Drop, a leader in the development of integrated digital therapeutics solutions for people with diabetes, whereby John Hancock Vitality life insurance customers will have direct access to One Drop’s diabetes management mobile app and curated content.

COLLABORATION PARTNERSHIP

#insurance

View Analyst & Ambassador Comments
Go to original news
Dec 21,2018

Nemaura Announces Completion of Key Stages of Technical File Review for SugarBEAT® CE Mark Approval

Nemaura Medical Inc., a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes and pre-diabetics, today announced that two of the three key stages for the CE Mark approval of sugarBEAT® have been completed.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 04,2017

WellDoc partners with American Diabetes Educators Association to add more educational content

WellDoc announced today a partnership with the American Association of Diabetes Educators (AADE), a professional membership organization of over 14,000 diabetes educators. WellDoc will incorporate educational content from AADE into its FDA-cleared, reimburseable BlueStar system for diabetes management.

COLLABORATION PARTNERSHIP

#product & service

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 05,2017

Intuity Medical gets another $15M to commercialize blood glucose monitoring system

Diabetes management device maker Intuity Medical has raised another $15 million in Series C funding in a round led by PTV Healthcare Capital, new investors KCK Group, and affiliates of Luther King Capital Management. Existing investors Accuitive Medical Ventures, Investor Growth Capital, US Venture Partners, Venrock and Versant Ventures also contributed to the round. The company, which makes an automatic blood glucose monitoring system called Pogo, raised $40 million just two months ago, bringing the Series total to $55 million. Pogo received FDA clearance in April 2016, and consists of a...

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jan 09,2017

Novo Nordisk teams up with Glooko for digital diabetes management

Mountain View, California-based Glooko is collaborating with Danish pharmaceutical company Novo Nordisk to develop a digital diabetes management platform. The non-exclusive partnership, developed and branded by both companies, will combine Glooko’s digital capabilities and Novo Nordisk’s deep knowledge of diabetes. Together, the companies will build on Glooko’s existing mobile and web platforms to improve population health reporting, plus create personalized digital services to support people with diabetes in areas like medication adherence and blood glucose management.

COLLABORATION PARTNERSHIP

#r&d

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES